Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
skin reaction; This non-serious case was reported by a consumer and described the occurrence of skin reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced skin reaction (Verbatim: skin reaction). The outcome of the skin reaction was not resolved. It was unknown if the reporter considered the skin reaction to be related to Shingrix. It was unknown if the company considered the skin reaction to be related to Shingrix. Additional Information: GSK Receipt Date: 03-FEB-2025 The reporter reported that he/she just got the Shingrix vaccine. He/she was not told that there were 2 shots. He/she had a skin reaction after the first dose which had not gone away.